Suppr超能文献

亚厘米肺腺癌患者中微乳头成分的预后影响:一项中国队列研究。

Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort study.

机构信息

Department of Thoracic Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Thorac Cancer. 2020 Dec;11(12):3566-3575. doi: 10.1111/1759-7714.13702. Epub 2020 Oct 15.

Abstract

BACKGROUND

In this study, we investigated the prognostic significance of a micropapillary (MP) component in patients with subcentimeter lung adenocarcinoma.

METHODS

A total of 311 patients with subcentimeter lung adenocarcinoma who underwent surgical resection between January 2009 to December 2012 from seven medical centers were included. Recurrence-free survival (RFS) and overall survival (OS) were analyzed.

RESULTS

The five-year RFS was 79.8% in 97 (97/311, 31%) cases of adenocarcinoma with a MP component and 93.5% in the 214 (214/311, 69%) cases without. In multivariate analysis, MP was an independent risk factor for worse RFS (hazard ratio [HR], 3.73; 95% confidence interval [CI]: 1.87-7.42; P < 0.001) and OS (HR, 5.84; 95% CI: 2.20-15.49; P < 0.001). There was no significant difference among wedge resection, segmentectomy and lobectomy on RFS (P = 0.256) and OS (P = 0.103) in patients without MP. Regarding patients with a MP component, lobectomy achieved equivalent prognosis than segmentectomy, and both were better than wedge resection (P = 0.001).

CONCLUSIONS

A MP component still suggest a poor prognosis in subcentimeter lung adenocarcinoma. Patients with subcentimeter lung adenocarcinoma with a MP component of 5% or greater treated with wedge resection were at higher risk of recurrence than patients treated with anatomical resection.

摘要

背景

本研究旨在探讨微乳头(MP)成分在亚厘米肺腺癌患者中的预后意义。

方法

纳入 2009 年 1 月至 2012 年 12 月期间,7 家医疗中心接受手术切除的 311 例亚厘米肺腺癌患者。分析无复发生存率(RFS)和总生存(OS)。

结果

97 例(31%,97/311)腺癌患者有 MP 成分,其 5 年 RFS 为 79.8%,214 例(69%,214/311)无 MP 成分的患者 5 年 RFS 为 93.5%。多因素分析显示,MP 是 RFS(风险比[HR],3.73;95%置信区间[CI]:1.87-7.42;P<0.001)和 OS(HR,5.84;95%CI:2.20-15.49;P<0.001)的独立危险因素。在无 MP 的患者中,楔形切除术、节段切除术和肺叶切除术之间在 RFS(P=0.256)和 OS(P=0.103)方面无显著差异。对于有 MP 成分的患者,肺叶切除术的预后与节段切除术相当,两者均优于楔形切除术(P=0.001)。

结论

MP 成分在亚厘米肺腺癌中仍提示预后不良。亚厘米肺腺癌伴 MP 成分 5%或以上的患者行楔形切除术复发风险高于行解剖性切除术的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0100/7705621/579b0d6900ac/TCA-11-3566-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验